Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chandan HealthcareNSE:CHANDAN -4.01%17 ROA % is 6.65% as of Dec. 2025, which is 23% below its 10-year median of 8.63. GuruFocus rates NSE:CHANDAN with a GF Score™ of 17/100. The stock has 4 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Chandan Healthcare ranks better than 75.59% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Chandan Healthcare's annualizedNet Income for the quarter that ended in Dec. 2025 was ₹182 Mil.
Chandan Healthcare's average Total Assets over the quarter that ended in Dec. 2025 was ₹2,732 Mil. Therefore, Chandan Healthcare's annualized ROA % for the quarter that ended in Dec. 2025 was 6.65%.
The historical rank and industry rank for Chandan Healthcare's ROA % or its related term are showing as below:
NSE:CHANDAN'
s ROA % Range Over the Past 10 Years
Min: -1.37 Med: 8.63 Max: 15.08
Current: 4.85
During the past 4 years, Chandan Healthcare's highest ROA % was 15.08%. The lowest was -1.37%. And the median was 8.63%.
NSE:CHANDAN's ROA % is ranked better than 75.59% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.39
vs NSE:CHANDAN: 4.85
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Chandan Healthcare ROA % Related Terms
Chandan Healthcare ROA % Historical Data
* Premium members only.
The historical data trend for Chandan Healthcare's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Chandan Healthcare's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandan Healthcare ROA % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Chandan Healthcare's ROA % distribution charts can be found below:
* The bar in red indicates where Chandan Healthcare's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Chandan Healthcare (NSE:CHANDAN) has a ROA % of 6.65% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Chandan Healthcare and its competitors. This is 23% below median its historical median of 8.63. According to the industry distribution chart, Chandan Healthcare ranks #52 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 24.4%.
Is Chandan Healthcare's ROA % too high?
Chandan Healthcare's current ROA % of 6.65% is 23% below median its 10-year median of 8.63. Based on the distribution chart, Chandan Healthcare ranks #52 out of 213 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Chandan Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Chandan Healthcare's ROA % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Chandan Healthcare ranks #52 out of 213 companies for ROA %. This places Chandan Healthcare in the top 24% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Diagnostics & Research company?
A good ROA % depends on the Medical Diagnostics & Research industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Chandan Healthcare and its competitors. Chandan Healthcare's current ROA % is 6.65%, which is 23% below median its own 10-year median of 8.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandan Healthcare stock overvalued right now?
Chandan Healthcare (NSE:CHANDAN) has a current ROA % of 6.65%. The current ROA % is 6.65%, which is 23% below median its 10-year median of 8.63. Chandan Healthcare's overall GF Score™ is 17/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Chandan Healthcare (NSE:CHANDAN), the current ROA % is 6.65% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
17GF Score
Get the complete analysis for NSE:CHANDAN
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CHANDAN has been successfully added to your 
